Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
San Marino, CA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
San Marino, CA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Santa Ana, CA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Sherman Oaks, CA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Colorado Springs, CO
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Denver, CO
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Denver, CO
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Hamden, CT
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Hamden, CT
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Atlantis, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Boca Raton, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Bradenton, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Brandon, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Brandon, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Brooksville, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Brooksville, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Clearwater, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Cutler Bay, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Cutler Bay, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Fort Lauderdale, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Hialeah, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Jacksonville, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Lauderdale Lakes, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Maitland, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Maitland, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Miami Lakes, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Miami Springs, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Miami Springs, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Miami, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Miami, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Naples, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Naples, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
North Miami Beach, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Orange Park, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Orange Park, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Orlando, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Ormond Beach, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Pembroke Pines, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Pinellas Park, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Port Orange, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Port Orange, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Tamarac, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Tamarac, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Tampa, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Williston, FL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Williston, FL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Atlanta, GA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Decatur, GA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Decatur, GA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Lilburn, GA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Lilburn, GA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Marietta, GA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Marietta, GA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Snellville, GA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Snellville, GA
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Blackfoot, ID
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Blackfoot, ID
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Boise, ID
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Boise, ID
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Meridian, ID
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Meridian, ID
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Blue Island, IL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Blue Island, IL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Chicago, IL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Evanston, IL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Evanston, IL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Hoffman Estates, IL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Morton, IL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Morton, IL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Oak Lawn, IL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Schaumburg, IL
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Schaumburg, IL
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Brownsburg, IN
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Brownsburg, IN
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Indianapolis, IN
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Wichita, KA
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Wichita, KA
Click here to add this to my saved trials